Sign Up to like & get
recommendations!
0
Published in 2021 at "Cell chemical biology"
DOI: 10.1016/j.chembiol.2021.03.007
Abstract: The therapeutic modality of targeted protein degradation promises to overcome limitations of traditional pharmacology. Small-molecule degraders recruit disease-causing proteins to E3 ubiquitin ligases, prompting their ubiquitination and degradation by the proteasome. The discovery, mechanistic elucidation,…
read more here.
Keywords:
multi omics;
molecule degraders;
small molecule;
selectivity profiling ... See more keywords